Advertisement

Topics

More Questions As Biocon Pulls EU Filings For Two Biosimilars

10:30 EDT 16 Aug 2017 | Elsevier Business Intelligence

Biocon and partner Mylan have withdrawn the European application for their biosimilar trastuzumab and pegfilgrastim in the ba...

Original Article: More Questions As Biocon Pulls EU Filings For Two Biosimilars

NEXT ARTICLE

More From BioPortfolio on "More Questions As Biocon Pulls EU Filings For Two Biosimilars"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Biosimilars
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...